Anxiety sensitivity, controllability, and experiential avoidance and their relation to drug of choice and addiction severity in a residential sample of substance-abusing veterans

Addictive Behaviors
John P ForsythCarlos G Finlay

Abstract

The aim of the present study was to evaluate anxiety-related psychological risk factors (e.g., anxiety sensitivity, perceived uncontrollability, emotional avoidance) and their relation to drug of choice and addiction severity in an inpatient residential substance abuse population. Fully detoxified veterans (N=94) meeting criteria for Axis I substance abuse disorders were enrolled in a 28-day residential substance abuse treatment program and completed the following measures at intake and discharge: Anxiety Sensitivity Index, Body Sensations Questionnaire (BSQ), Acceptance and Action Questionnaire (AAQ), Beck Depression Inventory (BDI; intake only), and the Anxiety Control Questionnaire (ACQ). Consistent with the expectation, veterans who reported more distress over bodily sensations (anxiety sensitivity, BSQ) and depressive symptoms (BDI) were more likely to avoid experiencing negative affect (AAQ) and perceived themselves as lacking in control (ACQ). Further, extent of avoidance, and to a lesser extent, controllability, discriminated between participants as a function of primary and comorbid diagnostic status, whereas anxiety sensitivity did not. No relation was found between anxiety sensitivity and drug of choice, and relation...Continue Reading

References

Jan 1, 1992·Journal of Substance Abuse Treatment·A T McLellanM Argeriou
Jan 1, 1990·Addictive Behaviors·S T Tiffany, D J Drobes
Jan 1, 1988·Annals of the New York Academy of Sciences·R A Wise
Jan 1, 1988·Advances in Alcohol & Substance Abuse·C R CloningerM Bohman
May 1, 1988·Journal of Abnormal Psychology·M L CooperW H George
Jan 1, 1986·Behaviour Research and Therapy·S ReissR J McNally
Dec 1, 1984·Journal of Consulting and Clinical Psychology·D L ChamblessR Gallagher
Jan 1, 1984·The British Journal of Psychiatry : the Journal of Mental Science·P SmailR Hodgson
Jan 1, 1984·The British Journal of Psychiatry : the Journal of Mental Science·T StockwellS Canter
Aug 1, 1980·Journal of Abnormal Psychology·R W LevensonD B Newlin
Jul 1, 1996·Behaviour Research and Therapy·B J CoxR P Swinson
May 1, 1997·Journal of Abnormal Psychology·N L CooneyL Gaupp
Mar 1, 1997·Journal of Anxiety Disorders·S H StewartJ M Baker
Mar 1, 1997·Journal of Anxiety Disorders·S Reiss
Sep 23, 1997·Behaviour Research and Therapy·G R NortonG J Asmundson
Jan 1, 1997·Journal of Substance Abuse·S H StewartR A Peterson
Aug 26, 1998·Psychological Reports·M M O'HaraN A Ricci
Mar 9, 2000·Addictive Behaviors·T J Johnson, K L Cropsey

❮ Previous
Next ❯

Citations

Aug 12, 2008·Prevention Science : the Official Journal of the Society for Prevention Research·Anthony BiglanJacqueline Pistorello
May 11, 2005·Journal of Behavior Therapy and Experimental Psychiatry·Matthew T FeldnerEllen W Leen-Feldner
Jan 4, 2013·Journal of Trauma & Dissociation : the Official Journal of the International Society for the Study of Dissociation (ISSD)·Jane M SundermannAnne P DePrince
Feb 25, 2009·Cognitive Behaviour Therapy·Rachel D PetersonKimberly Renk
Oct 21, 2015·Genes, Brain, and Behavior·D BelinJ W Dalley
Apr 15, 2008·Journal of Anxiety Disorders·Karen L Sokolowski, Allen C Israel
Jan 24, 2007·Behaviour Research and Therapy·Roman KotovNorman B Schmidt
Jul 21, 2004·Journal of Behavior Therapy and Experimental Psychiatry·Jennifer C PlumbJane A Luterek
Jul 8, 2008·Journal of Psychiatric Research·Jasper A J SmitsAnke Seidel
Nov 23, 2005·Behaviour Research and Therapy·Steven C HayesJason Lillis
Jun 24, 2010·Behavior Therapy·Michael P Twohig, Jesse M Crosby
Jan 24, 2009·Clinical Psychology & Psychotherapy·Joanna Coggins, John R E Fox
Aug 4, 2007·Journal of Clinical Psychology·Neharika Chawla, Brian Ostafin
Dec 5, 2009·Journal of Traumatic Stress·Katherine L StephensonHolly K Orcutt
May 23, 2014·Journal of Science and Medicine in Sport·John BaranoffJason P Connor
Jun 23, 2010·Behaviour Research and Therapy·Amanda J ShallcrossIris B Mauss
Aug 9, 2008·Behaviour Research and Therapy·Jasper A J SmitsMark B Powers
Mar 14, 2009·Behaviour Research and Therapy·Stefan G HofmannAnu Asnaani
Jun 9, 2017·Journal of Psychoactive Drugs·Blaise L WordenDavid F Tolin
Mar 24, 2010·Behavior Modification·Jessica KingstonBob Remington
Apr 5, 2007·Behavior Modification·Michael J Zvolensky, Norman B Schmidt
Feb 20, 2007·Behavior Modification·Norman B SchmidtMeghan E Keough
Jan 10, 2006·Depression and Anxiety·Ariel J Lang, Dale E McNiel
Apr 27, 2019·Journal of Clinical and Experimental Neuropsychology·Jony SheyninAhmed A Moustafa
Jul 2, 2016·Journal of Behavioral Addictions·Carlos García-Oliva, José A Piqueras
May 14, 2020·Psychology, Health & Medicine·Dorothy I UgwuJohnBosco C Chukwuorji
Feb 15, 2019·Frontiers in Psychology·Alexandra GhiţăJosé Gutiérrez-Maldonado
Sep 24, 2020·Journal of Clinical Medicine·Olga Hernández-SerranoJosé Gutiérrez-Maldonado
Sep 26, 2019·Suicide & Life-threatening Behavior·Ioannis Angelakis, Patricia Gooding

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.